Trials / Sponsors / Silence Therapeutics GmbH
Silence Therapeutics GmbH
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) Carcinoma, Pancreatic Ductal | Phase 1 / Phase 2 | 2013-03-01 |
| Completed | Study With Atu027 in Patients With Advanced Solid Cancer Advanced Solid Tumors | Phase 1 | 2009-06-01 |